A host of medical devices—including imaging equipment, pacemakers and electrocardiographs—are included in the list of Chinese products that will be hit with a 25 percent tariff beginning July 6, the U.S. government announced Friday.
An early discharge strategy with rivaroxaban reduces hospital lengths of stay and healthcare costs for patients with low-risk pulmonary embolism (LRPE)—without compromising their safety—suggests a study published in Academic Emergency Medicine.
The American Medical Association House of Delegates pledged on June 11 to advance gender equity in medicine after multiple studies highlighted the wage gap and discrimination women physicians continue to face.
A Boston-area cardiologist and an advocate against nuclear weapons met with North Korean diplomats ahead of the 2018 United States-North Korea Summit in Singapore, reports WFXT, the FOX affiliate in Boston.
Boston Scientific said Monday it won't comment on reports rival medical device manufacturer Stryker made a takeover bid. The news was first reported by The Wall Street Journal. Stryker also stated it does not comment on potential mergers or acquisitions.
Anheuser-Busch InBev decided to pull funding from a long-term study of moderate alcohol intake and its effects on cardiovascular health after concerns were raised about the objectivity of the research.
The American Heart Association (AHA) expressed worry over the relatively flat rate of e-cigarette use among middle and high school students, saying the decline in tobacco use must continue before another generation becomes lifelong addicts.
Risk adjustment models for acute myocardial infarction (AMI) used by CMS suggest a diagnosis of atherosclerosis is associated with about a 40 percent reduction in 30-day mortality for Medicare beneficiaries. Researchers found hospitals that provide more extensive cardiac care are more likely to report the condition, thereby skewing the risk models.
Physicians working in states that imposed damage caps for malpractice claims were less likely to perform invasive coronary angiography and percutaneous coronary intervention (PCI) than colleagues in no-cap states, according to a new study in JAMA Cardiology.
The average hospital stay for pediatric patients requiring a ventricular assist device (VAD) spans nearly three months and costs $750,000, according to research in the Journal of the American Heart Association.
Patients who required permanent pacemakers (PPMs) after transcatheter aortic valve replacement (TAVR) demonstrated lower survival rates and higher comorbidity burdens over a multiyear follow-up. However, they didn’t accumulate significantly greater healthcare costs, according to a study published online May 25 in JAMA Network Open.
Pfizer gave more than $10 million to a charity for heart patients while dramatically increasing the price of one of its antiarrhythmic drugs, deflecting costs from patients and leaving Medicare with a bigger bill, the U.S. Justice Department said in a May 24 settlement statement.
Once more expensive P2Y12 inhibitors hit the U.S. market, the percentage of patients not filling prescriptions for any P2Y12 inhibitor after percutaneous coronary intervention (PCI) increased from 6 percent to 19 percent, researchers reported in JAMA Internal Medicine.